Vinit Karmali

2.1k total citations · 1 hit paper
14 papers, 1.4k citations indexed

About

Vinit Karmali is a scholar working on Surgery, Molecular Biology and Physiology. According to data from OpenAlex, Vinit Karmali has authored 14 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 4 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Vinit Karmali's work include Coronary Interventions and Diagnostics (4 papers), Erythrocyte Function and Pathophysiology (2 papers) and Iron Metabolism and Disorders (2 papers). Vinit Karmali is often cited by papers focused on Coronary Interventions and Diagnostics (4 papers), Erythrocyte Function and Pathophysiology (2 papers) and Iron Metabolism and Disorders (2 papers). Vinit Karmali collaborates with scholars based in United States, Denmark and South Korea. Vinit Karmali's co-authors include Andrew N. Young, Andrew S. Neish, Anjali Rao, James Madara, Andrew T. Gewirtz, Michael E. Hobert, Hui Zeng, Aloke V. Finn, Rohini Polavarapu and Frank D. Kolodgie and has published in prestigious journals such as Science, Nature Communications and Journal of Neuroscience.

In The Last Decade

Vinit Karmali

13 papers receiving 1.4k citations

Hit Papers

Prokaryotic Regulation of Epithelial Responses by Inhibit... 2000 2026 2008 2017 2000 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vinit Karmali United States 11 582 429 249 226 175 14 1.4k
Mairi H McLean United Kingdom 18 759 1.3× 417 1.0× 389 1.6× 140 0.6× 111 0.6× 34 1.8k
Laurence Martin France 12 420 0.7× 476 1.1× 151 0.6× 160 0.7× 94 0.5× 13 1.2k
Corinne Lebreton France 18 704 1.2× 416 1.0× 302 1.2× 112 0.5× 97 0.6× 34 1.8k
David Jones United States 16 539 0.9× 273 0.6× 477 1.9× 140 0.6× 89 0.5× 41 1.7k
Markus Utech Germany 15 805 1.4× 191 0.4× 471 1.9× 165 0.7× 138 0.8× 27 1.8k
Goo‐Young Seo South Korea 19 537 0.9× 498 1.2× 201 0.8× 93 0.4× 234 1.3× 38 1.4k
O Eunju South Korea 13 593 1.0× 282 0.7× 110 0.4× 115 0.5× 141 0.8× 18 1.1k
Takehito Sato Japan 25 732 1.3× 1.1k 2.6× 170 0.7× 254 1.1× 211 1.2× 89 2.3k
Yaíma L. Lightfoot United States 17 440 0.8× 406 0.9× 139 0.6× 105 0.5× 84 0.5× 23 1.1k
Clémentine Perrier Belgium 15 430 0.7× 293 0.7× 185 0.7× 115 0.5× 144 0.8× 25 1.2k

Countries citing papers authored by Vinit Karmali

Since Specialization
Citations

This map shows the geographic impact of Vinit Karmali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vinit Karmali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vinit Karmali more than expected).

Fields of papers citing papers by Vinit Karmali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vinit Karmali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vinit Karmali. The network helps show where Vinit Karmali may publish in the future.

Co-authorship network of co-authors of Vinit Karmali

This figure shows the co-authorship network connecting the top 25 collaborators of Vinit Karmali. A scholar is included among the top collaborators of Vinit Karmali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vinit Karmali. Vinit Karmali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kao, Carol, Christina A. Rostad, L. Nolan, et al.. (2024). A Phase 1, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin) Vaccine in Healthy US Adults. The Journal of Infectious Diseases. 230(5). 1093–1101. 9 indexed citations
2.
Sherman, Amy C, Lilin Lai, Mary Bower, et al.. (2020). The Effects of Imprinting and Repeated Seasonal Influenza Vaccination on Adaptive Immunity after Influenza Vaccination. Vaccines. 8(4). 663–663. 10 indexed citations
3.
Finn, Aloke V., Hirokuni Akahori, Liang Guo, et al.. (2016). ALTERNATIVE MACROPHAGES PROMOTE INTRAPLAQUE ANGIOGENESIS AND VASCULAR PERMEABILITY IN HUMAN ATHEROSCLEROSIS. Journal of the American College of Cardiology. 67(13). 2241–2241.
4.
Akahori, Hirokuni, Vinit Karmali, Rohini Polavarapu, et al.. (2015). CD163 interacts with TWEAK to regulate tissue regeneration after ischaemic injury. Nature Communications. 6(1). 7792–7792. 79 indexed citations
5.
Habib, Anwer, Rohini Polavarapu, Vinit Karmali, et al.. (2015). Hepcidin-ferroportin axis controls toll-like receptor 4 dependent macrophage inflammatory responses in human atherosclerotic plaques. Atherosclerosis. 241(2). 692–700. 31 indexed citations
6.
Habib, Anwer, Vinit Karmali, Michael C. John, et al.. (2014). Everolimus-Eluting Stents Improve Vascular Response in a Diabetic Animal Model. Circulation Cardiovascular Interventions. 7(4). 526–532. 12 indexed citations
7.
Habib, Anwer, Vinit Karmali, Rohini Polavarapu, et al.. (2013). Metformin Impairs Vascular Endothelial Recovery After Stent Placement in the Setting of Locally Eluted Mammalian Target of Rapamycin Inhibitors Via S6 Kinase-Dependent Inhibition of Cell Proliferation. Journal of the American College of Cardiology. 61(9). 971–980. 34 indexed citations
8.
Habib, Anwer, et al.. (2013). Metformin impairs endothelialization after placement of Newer Generation Drug Eluting Stents. Atherosclerosis. 229(2). 385–387. 11 indexed citations
9.
Habib, Anwer, Vinit Karmali, Rohini Polavarapu, et al.. (2013). Sirolimus-FKBP12.6 Impairs Endothelial Barrier Function Through Protein Kinase C-α Activation and Disruption of the p120–Vascular Endothelial Cadherin Interaction. Arteriosclerosis Thrombosis and Vascular Biology. 33(10). 2425–2431. 50 indexed citations
10.
Finn, Aloke V., Masataka Nakano, Rohini Polavarapu, et al.. (2011). Hemoglobin Directs Macrophage Differentiation and Prevents Foam Cell Formation in Human Atherosclerotic Plaques. Journal of the American College of Cardiology. 59(2). 166–177. 255 indexed citations
11.
Saeed, Omar, Fumiyuki Otsuka, Rohini Polavarapu, et al.. (2011). Pharmacological Suppression of Hepcidin Increases Macrophage Cholesterol Efflux and Reduces Foam Cell Formation and Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 32(2). 299–307. 122 indexed citations
12.
Finn, Aloke V., Michael C. John, Gaku Nakazawa, et al.. (2009). Differential Healing After Sirolimus, Paclitaxel, and Bare Metal Stent Placement in Combination With Peroxisome Proliferator-Activator Receptor γ Agonists. Circulation Research. 105(10). 1003–1012. 23 indexed citations
13.
Dodson, Sara E., Olav M. Andersen, Vinit Karmali, et al.. (2008). Loss of LR11/SORLA Enhances Early Pathology in a Mouse Model of Amyloidosis: Evidence for a Proximal Role in Alzheimer's Disease. Journal of Neuroscience. 28(48). 12877–12886. 101 indexed citations
14.
Neish, Andrew S., Andrew T. Gewirtz, Hui Zeng, et al.. (2000). Prokaryotic Regulation of Epithelial Responses by Inhibition of IκB-α Ubiquitination. Science. 289(5484). 1560–1563. 668 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026